Section
Deals
M&A, licensing, and major transactions shaping the industry
DealsPharmaceutical Technology ↗
Zydus Lifesciences is set to acquire all outstanding Assertio common shares in a $166.4m deal, via its subsidi…
DealsFierceBiotech ↗
Novo Nordisk has found the latest buyer for one of its orphaned cell therapies.…
DealsEndpoints News ↗
Bayer is back on the market for drug acquisitions after a half-decade on the sidelines, according to CEO Bill …
DealsBriefing
Bristol Myers Squibb will pay $600M upfront in a $15.2B collaboration with Hengrui, aiming to leverage China’s…
DealsBioPharma Dive ↗
The marketing deal is the latest in a series of recent pacts between GSK and China-based drug companies, and c…
DealsFierceBiotech ↗
For people living with exocrine pancreatic insufficiency due to cystic fibrosis, the only treatment option is …
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.